litlas
Log inCreate account

Charles A. Dinarello

Active 1974–2024

Also published as
CHARLES A. DINARELLO
495
Papers
137,684
Citations
202
h-index
492
i10-index

Citations

Citations per year for Charles A. Dinarello1962: 1 citations1964: 1 citations1972: 1 citations1974: 1 citations1976: 5 citations1977: 4 citations1978: 10 citations1979: 15 citations1980: 8 citations1981: 12 citations1982: 27 citations1983: 30 citations1984: 96 citations1985: 80 citations1986: 198 citations1987: 270 citations1988: 453 citations1989: 619 citations1990: 685 citations1991: 700 citations1992: 655 citations1993: 646 citations1994: 555 citations1995: 543 citations1996: 519 citations1997: 542 citations1998: 547 citations1999: 627 citations2000: 714 citations2001: 763 citations2002: 754 citations2003: 745 citations2004: 738 citations2005: 634 citations2006: 822 citations2007: 752 citations2008: 725 citations2009: 808 citations2010: 891 citations2011: 1,139 citations2012: 1,083 citations2013: 1,271 citations2014: 1,244 citations2015: 1,243 citations2016: 1,223 citations2017: 1,508 citations2018: 1,309 citations2019: 3,977 citations2020: 4,505 citations2021: 4,375 citations2022: 3,809 citations2023: 2,701 citations2024: 3,643 citations2025: 1,751 citations2026: 43 citations1963: no citations, so this year is not shown1965–1971: no citations, so these years are not shown1973: no citations, so this year is not shown1975: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 13,623 citing papers, 28% of this breakdownChina: 5,557 citing papers, 11.4% of this breakdownUnited Kingdom: 2,868 citing papers, 5.9% of this breakdownGermany: 2,862 citing papers, 5.9% of this breakdownItaly: 2,222 citing papers, 4.6% of this breakdownJapan: 1,539 citing papers, 3.2% of this breakdownCanada: 1,530 citing papers, 3.1% of this breakdownFrance: 1,481 citing papers, 3% of this breakdownNetherlands: 1,478 citing papers, 3% of this breakdownAustralia: 1,241 citing papers, 2.5% of this breakdownSpain: 1,010 citing papers, 2.1% of this breakdownSwitzerland: 970 citing papers, 2% of this breakdown
0%28%Other 25.3%

Institutions

Fields

  • Medicine42.6%
  • Biochemistry, Genetics and Molecular Biology23.9%
  • Immunology and Microbiology18.4%
  • Neuroscience8%
  • Nursing2.3%
  • Agricultural and Biological Sciences1.3%
  • Other3.5%

Topics

  • Inflammasome and immune disorders4.8%
  • Immune Response and Inflammation3.6%
  • Neuroinflammation and Neurodegeneration Mechanisms2.6%
  • Immune Cell Function and Interaction2.3%
  • Alzheimer's disease research and treatments1.9%
  • Immune cells in cancer1.8%
  • Other83%

Coauthors

All papers

Open in search
  1. Neuroinflammation in Alzheimer's disease

    Authors: Michael T. Heneka, Monica J. Carson, Joseph El Khoury, Gary E. Landreth, Frederic Brosseron, Douglas L. Feinstein, Andreas H. Jacobs, Tony Wyss‐Coray, Javier Vitórica, Richard M. Ransohoff, Karl Herrup, Sally A. Frautschy, Bente Finsen, Guy C. Brown, Alexei Verkhratsky, Koji Yamanaka, Jari Koıstınaho, Eicke Latz, Annett Halle, Gabor C. Petzold, Terrence Town, Dave Morgan, Mari L. Shinohara, V. Hugh Perry, Clive Holmes, Nicolás G. Bazán, David J. Brooks, Stéphane Hunot, Bertrand Joseph, Nikolaus Deigendesch, Olga Garaschuk, Erik Boddeke, Charles A. Dinarello, John C.S. Breitner, Greg M. Cole, Douglas T. Golenbock, Markus P. Kummer - The Lancet Neurology 2015 cited by 6,102

  2. Overview of the IL‐1 family in innate inflammation and acquired immunity

    Authors: Charles A. Dinarello - Immunological Reviews 2017 cited by 1,828

  3. Interleukins in cancer: from biology to therapy

    Authors: Daria Briukhovetska, Janina Dörr, Stefan Endres, Peter Libby, Charles A. Dinarello, Sebastian Kobold - Nature reviews. Cancer 2021 cited by 765

  4. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity

    Authors: Alberto Mantovani, Charles A. Dinarello, Martina Molgora, Cecília Garlanda - Immunity 2019 cited by 1,036

  5. Immunological and Inflammatory Functions of the Interleukin-1 Family

    Authors: Charles A. Dinarello - Annual Review of Immunology 2009 cited by 3,432

  6. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

    Authors: Antonio Abbate, Stefano Toldo, Carlo Marchetti, Jordana Kron, Benjamín W. Van Tassell, Charles A. Dinarello - Circulation Research 2020 cited by 714

  7. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

    Authors: Charles A. Dinarello - Blood 2011 cited by 2,222

  8. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity

    Authors: Rob J.W. Arts, Boris Novakovic, Rob ter Horst, Agostinho Carvalho, Siroon Bekkering, Ekta Lachmandas, Fernando Rodrigues, Ricardo Silvestre, Shih‐Chin Cheng, Shuang-Yin Wang, Ehsan Habibi, Luís G. Gonçalves, Inês Mesquita, Cristina Cunha, Arjan van Laarhoven, Frank L. van de Veerdonk, David L. Williams, J.W.M. van der Meer, Colin Logie, Luke O'neill, Charles A. Dinarello, Niels P. Riksen, Reinout van Crevel, Clary B. Clish, Richard A. Notebaart, Leo A. B. Joosten, Hendrik G. Stunnenberg, Ramnik J. Xavier, Mihai G. Netea - Cell Metabolism 2016 cited by 858

  9. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

    Authors: Carlo Marchetti, Benjamin J. Swartzwelter, Fabia Gamboni, C. Preston Neff, Katrin Richter, Tania Azam, Sonia Carta, Isak W. Tengesdal, Travis Nemkov, Angelo D’Alessandro, Curtis J. Henry, Gerald S. Jones, Scott A. Goodrich, Joseph P. St. Laurent, Terry M. Jones, Curtis L. Scribner, Robert B. Barrow, Roy D. Altman, Damaris B. Skouras, Marco Gattorno, Veronika Grau, Sabina Janciauskiene, Anna Rubartelli, Leo A. B. Joosten, Charles A. Dinarello - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 559

  10. The Interleukin-1 Family: Back to the Future

    Authors: Cecília Garlanda, Charles A. Dinarello, Alberto Mantovani - Immunity 2013 cited by 1,918

  11. A guiding map for inflammation

    Authors: Mihai G. Netea, Frances R. Balkwill, Michel Chonchol, Fabio Cominelli, Marc Y. Donath, Evangelos J. Giamarellos‐Bourboulis, Douglas T. Golenbock, Mark S. Gresnigt, Michael T. Heneka, Hal M. Hoffman, Richard S. Hotchkiss, Leo A. B. Joosten, Daniel L. Kastner, Martin Körte, Eicke Latz, Peter Libby, Thomas Mandrup‐Poulsen, Alberto Mantovani, Kingston H. G. Mills, Kristen L. Nowak, Luke O'neill, Peter Pickkers, Tom van der Poll, Paul M. Ridker, Joost Schalkwijk, David A. Schwartz, Britta Siegmund, Clifford J. Steer, Herbert Tilg, Jos W.M. van der Meer, Frank L. van de Veerdonk, Charles A. Dinarello - Nature Immunology 2017 cited by 823

  12. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

    Authors: Charles A. Dinarello, Anna Simon, Jos W.M. van der Meer - Nature Reviews Drug Discovery 2012 cited by 1,757

  13. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome

    Authors: Bita Shakoory, Joseph A. Carcillo, W. Winn Chatham, Richard Amdur, Huaqing Zhao, Charles A. Dinarello, Randall Q. Cron, Steven M. Opal - Critical Care Medicine 2015 cited by 854

  14. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease

    Authors: Niklas Lonnemann, Shirin Hosseini, Carlo Marchetti, Damaris B. Skouras, Davide Stefanoni, Angelo D’Alessandro, Charles A. Dinarello, Martin Körte - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 293

  15. Anti-inflammatory Agents: Present and Future

    Authors: Charles A. Dinarello - Cell 2010 cited by 1,103

  16. Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases

    Authors: Giulio Cavalli, Serena Colafrancesco, Giacomo Emmi, Massimo Imazio, Giuseppe Lopalco, Maria Cristina Maggio, Jurgen Sota, Charles A. Dinarello - Autoimmunity Reviews 2021 cited by 331

  17. Targeting innate immune mediators in type 1 and type 2 diabetes

    Authors: Marc Y. Donath, Charles A. Dinarello, Thomas Mandrup‐Poulsen - Nature reviews. Immunology 2019 cited by 418

  18. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation

    Authors: Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, Avishai Shemesh, Galina V. Shurin, Michael R. Shurin, Charles A. Dinarello, Elena Voronov, Ron N. Apte - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 437

  19. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

    Authors: Viola Klück, Tim Jansen, M. Janssen, Antoaneta Comarniceanu, M. Efdé, Isak W. Tengesdal, Kiki Schraa, Maartje C. P. Cleophas, Curtis L. Scribner, Damaris B. Skouras, Carlo Marchetti, Charles A. Dinarello, Leo A. B. Joosten - The Lancet Rheumatology 2020 cited by 290

  20. Proinflammatory Cytokines

    Authors: Charles A. Dinarello - CHEST Journal 2000 cited by 2,020

  21. Interleukin-18 and IL-18 Binding Protein

    Authors: Charles A. Dinarello, Daniela Novick, Soohyun Kim, Gilles Kaplanski - Frontiers in Immunology 2013 cited by 934

  22. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion

    Authors: Isak W. Tengesdal, Dinoop Ravindran Menon, Douglas G. Osborne, C. Preston Neff, Nicholas E. Powers, Fabia Gamboni, Adolfo G Mauro, Angelo D’Alessandro, Davide Stefanoni, Morkos A. Henen, Taylor Mills, Dennis M. de Graaf, Tania Azam, Beat Vögeli, Brent E. Palmer, Eric M. Pietras, James DeGregori, Aik Choon Tan, Leo A. B. Joosten, Mayumi Fujita, Charles A. Dinarello, Carlo Marchetti - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 193

  23. The IL-1 family of cytokines and receptors in rheumatic diseases

    Authors: Charles A. Dinarello - Nature Reviews Rheumatology 2019 cited by 367

  24. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis

    Authors: Alba Sánchez‐Fernández, Damaris B. Skouras, Charles A. Dinarello, Rubén López‐Vales - Frontiers in Immunology 2019 cited by 166